$4,033.66 travel Payment -- Takeda Pharmaceuticals to Dr. Timothy Rogers

Takeda Pharmaceuticals covers travel and lodging for Gastroenterologist Timothy Rogers for Rybelsus.

This page provides a detailed analysis of a $4,033.66 travel payment from Takeda Pharmaceuticals to Dr. Timothy Rogers. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$4,033.66
Payment Typetravel
Payment NatureTravel and Lodging
Pharmaceutical CompanyTakeda Pharmaceuticals
PhysicianDr. Timothy Rogers
NPI Number1545175861
Physician SpecialtyGastroenterology
LocationCity, MO
Date of Payment2026-04-04
Related Drug/DeviceRybelsus
Conflict AssessmentLow -- Routine

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Takeda Pharmaceuticals made a $4.0K travel payment to Timothy Rogers, a Gastroenterology specialist in City, MO. The payment was associated with Rybelsus. The payment of $4,033.66 to Dr. Timothy Rogers was for travel and lodging related to Rybelsus. This payment was made by Takeda Pharmaceuticals on April 4, 2026. Dr. Rogers' specialty is Gastroenterology.

Patient Guidance: What This Payment Means for You

This payment covers travel and lodging expenses, which may be related to educational events or consultations concerning Rybelsus. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Travel and lodging payments are common in the pharmaceutical industry to facilitate physician education and engagement with new treatments.

Regulatory Context: Sunshine Act Requirements

Payments to physicians for travel and lodging must be reported under the Open Payments program and are subject to review for compliance with regulations like the Sunshine Act.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $4.0K payment for?

This was a travel payment of $4.0K from Takeda Pharmaceuticals to Timothy Rogers, categorized as "Travel and Lodging". It was associated with Rybelsus. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Timothy Rogers accept pharmaceutical money?

Yes, Timothy Rogers received this $4.0K payment from Takeda Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Timothy Rogers's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $4.0K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Gastroenterology?

To compare this payment against Gastroenterology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Gastroenterology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Timothy Rogers's relationship with Takeda Pharmaceuticals?

The payment amount is $4,033.66. This $4.0K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Gastroenterology?

The payment type is 'travel'.

What should patients do after learning about this payment?

This payment covers travel and lodging expenses, which may be related to educational events or consultations concerning Rybelsus.

What else should I know about this travel payment?

The payment nature is 'Travel and Lodging'.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.